iRhythm Technologies, Inc.

NASDAQ:IRTC

Medical - Devices

Healthcare
$94.87 +0.35%

+$0.36 today

Market cap
$3.19B
Beta
1.28
P/E (TTM)
-119.5
EPS (TTM)
-$0.85
52W Low $100.85High $212.00

Volume 1.20M

Average 0.52M

IRTC EBITDA Margin

EBITDA as a percentage of revenue.

iRhythm Technologies, Inc.NASDAQ: IRTC

EBITDA Margin · Q3 FY2026 · quarter ended Sep 2026

EBITDA Margin narrows to -14.7%

EBITDA Margin was -14.7% in Q3 FY2026, down 17.1 pp from a year earlier. On a trailing-twelve-month basis it was -1.2%, up 0.4 pp year over year. Over 3 fiscal years it widened by 21.9 pp.

Context

  • EBITDA Margin widened in 3 of the last 3 fiscal years.
  • FY2025 was the highest level in the 4 fiscal years shown.

What to watch

Whether EBITDA Margin reaches the consensus estimate from 11 analysts of 4.8% for the fiscal year ending Dec 2026, up from -0.5% in FY2025.

Sources:Income Statement Analyst consensus estimates Text generated from reported figures; not investment advice.

Latest quarterSep 2026
-14.7%-19.0 pp QoQ
Last fiscal yearDec 2025
-0.5%+12.0 pp YoY
LTMSep 2026
-1.2%+0.4 pp YoY
EBITDA Margin past and forecast change by horizon
Horizon Past Forecast Difference
Quarter-17.1 pp-1.3 pp+15.9 pp
1 year+12.0 pp+5.3 pp-6.7 pp
3 years+21.9 pp+13.1 pp-8.8 pp
5 years+19.1 pp—
10 years——

Forecasts compare the consensus estimate with the latest reported period. Difference is forecast minus past, in percentage points.

EBITDA Margin history

Percent of revenue · from the income statement

Latest · FY2025
-0.5%
Year-over-year change
+12.0pp
Reported Analyst consensus estimate Further estimates hidden. Sign in to unlock

EBITDA Margin vs competitors

How IRTC compares with its peers on the latest reported figures

  • IRTC's LTM Sep 2026 EBITDA Margin of -1.2% is the 6th highest of the 7 companies compared; the peer median is 14.4%.
  • Its year-over-year change of +0.4 pp is the 4th highest of 7, against a peer median of +1.1 pp.
  • Over three fiscal years its change of +21.9 pp compares with a peer median of +3.8 pp.
IRTC Competitors Peer median
EBITDA Margin for IRTC and competitors
Company Period LTM level YoY 3-year change
BSXBoston Scientific CorporationLTM Jun 202627.6% +2.2 pp+3.8 pp
MDTMedtronic plcLTM Jul 202627.3% +0.0 pp-0.9 pp
PENPenumbra, Inc.LTM Jun 202614.8% -0.4 pp+12.4 pp
LIVNLivaNova PLCLTM Sep 202614.0% +20.0 pp-12.4 pp
ATRCAtriCure, Inc.LTM Jun 20266.6% +8.5 pp+12.0 pp
IRTCiRhythm Technologies, Inc.LTM Sep 2026-1.2% +0.4 pp+21.9 pp
KMTSKestra Medical Technologies, Ltd.LTM Jan 2026-152.9% -23.0 pp—
Peer median (excluding IRTC) 14.4%+1.1 pp+3.8 pp

Competitors are the stored peer set for IRTC. Fiscal calendars differ, so each company's latest period is shown. Text is generated from reported figures; not investment advice.

Income Statement

USD
Metric
FY2021
Dec 2021
FY2022
Dec 2022
FY2023
Dec 2023
FY2024
Dec 2024
FY2025
Dec 2025
Revenue322.83M410.92M492.68M591.84M747.14M
Cost of Revenue109.26M129.29M160.88M184.31M219.89M
Gross Profit213.57M281.63M331.81M407.53M527.25M
Gross Margin66.2%68.5%67.3%68.9%70.6%
Research & Development38.67M46.61M60.24M103.83M84.61M
Selling, General & Admin274.84M322.2M385.65M418.57M479.45M
Operating Expenses313.51M395.42M456.97M523.04M564.06M
Depreciation & Amortization16.59M19.61M22.14M25.78M26.48M
EBITDA(83.23M)(92.14M)(96.86M)(74.13M)(3.97M)
EBITDA Margin-25.8%-22.4%-19.7%-12.5%-0.5%
Operating Income(99.94M)(113.78M)(125.16M)(115.51M)(36.81M)
Operating Margin-31.0%-27.7%-25.4%-19.5%-4.9%
Interest Income118K2.35M6.16M21.94M21.52M
Interest Expense1.17M4.14M3.65M12.82M13.15M
Other Income / Expenses(1.05M)(2.1M)2.51M2.78M(6.79M)
Income Before Tax(100.99M)(115.89M)(122.66M)(112.72M)(43.6M)
Pre-Tax Margin-31.3%-28.2%-24.9%-19.0%-5.8%
Income Tax Expense367K269K750K565K953K
Net Income(101.36M)(116.16M)(123.41M)(113.29M)(44.55M)
Net Margin-31.4%-28.3%-25.0%-19.1%-6.0%
EPS (Basic)(3.46)(3.88)(4.04)(3.63)(1.39)
EPS (Diluted)(3.46)(3.88)(4.04)(3.63)(1.39)
Weighted Avg Shares29.33M29.92M30.53M31.2M32M
Weighted Avg Shares (Diluted)29.33M29.92M30.53M31.2M32M

iRhythm Technologies, Inc.

NASDAQ:IRTC

Intrinsic Alpha fair value

Locked

Current Price

$94.87

Margin of safety hidden

Unlock the intrinsic value to see where the current price sits on the valuation runway.

Valuation runway

Locked

Get the intrinsic value and margin of safety with a free account.